Exchange Bulletin

iShares Genomics Immunology and Healthcare Index ETF (XDNA) To Trade On Toronto Stock Exchange


April 28, 2022

Issuer: iShares Genomics Immunology and Healthcare Index ETF (the "ETF")

SecuritySymbolIssued and Outstanding SecuritiesReserved SecuritiesIssue Price
Canadian dollar denominated units (the "CAD Units") XDNA 125,000 None $40.00
Listing category: Non-Corporate
Trading currency: CDN$
Transaction: Initial public offering of CAD Units (the "Offering")
Anticipated closing date: April 28, 2022
Listing date: April 29, 2022 (as at 5:01 p.m.) subject to confirmation of closing of the Offering.
Posted for trading date: May 2, 2022 (at the opening) subject to confirmation of closing of the Offering.
Other market(s): None
Designated market maker: National Bank Financial Inc.
Security ownership registration: CDS book-entry system, which will be effected in non-certificated form.
Investor relations: Steven Leong
Director, iShares Canada
416-933-6410
Steven.leong@blackrock.com 
Incorporation: The ETF is an exchange-traded fund established as a trust under the laws of the Province of Ontario pursuant to the amended and restated Declaration of Trust dated April 13, 2022.
Manager and Trustee: BlackRock Asset Management Canada Limited
Fiscal year end: December 31
Nature of business: The ETF seeks to provide long-term growth by replicating the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index.
Transfer agent and registrar: State Street Trust Company Canada at its principal office in Toronto.
Distributions: Cash distributions on CAD Units of the ETF are expected to be made on a semi-annual basis.
Sponsorship: Not applicable
Offering document: Prospectus dated April 13, 2022 (the "Prospectus"), which is available at www.SEDAR.com. Capitalized terms not otherwise defined herein are as defined in the Prospectus.
Initial public offering: 125,000 CAD Units at a price of $40.00 per CAD Unit. CAD Units are being issued and sold on a continuous basis and there is no maximum number of CAD Units that may be issued.
TSX contact: Selma Thaver,
Director,
TSX Listings